Asian, Black Men With HIV Less Likely to Get Anal-Cancer Screening Asian, Black Men With HIV Less Likely to Get Anal-Cancer Screening

Asian men with HIV are much less likely than their white peers to have discussed anal-cancer screening with a healthcare provider, new findings from Canada show.Reuters Health Information
Source: Medscape Hiv-Aids Headlines - Category: Infectious Diseases Tags: Pathology & Lab Medicine News Source Type: news

Related Links:

Conclusions: In this series, anal hrHPV DNA testing offered 92% NPV for PLWHA; in other words, a 8% risk of occult precancer remains for those who test hrHPV negative on anal swab samples. PMID: 32411239 [PubMed]
Source: Journal of Oncology - Category: Cancer & Oncology Tags: J Oncol Source Type: research
ConclusionHIV positivity is associated with increased prevalence of HPV infection on different anatomic sites, which will result in increased burden of HPV-related cancers among PLHIV. Furthermore, primary studies with robust study designs aimed at investigating the risk developing HPV-related cancers among PLHIV are recommended.Systematic review registration: PROSPERO CRD42017062403
Source: Systematic Reviews - Category: International Medicine & Public Health Source Type: research
ConclusionsThrough the study it was possible to construct a flow of referrals from the SAE to the UFSJ Coloproctology outpatient clinic. Moreover, the existence of internal stigmas on the part of the participants regarding the proctological examination and the lack of information about anal cancer screening are challenges to be overcome.ResumoObjetivos do estudoRealizar o rastreamento de lesões anais e câncer anal em homens vivendo com HIV/AIDS.MétodosTrata-se de estudo descritivo observacional transversal, cujos dados foram obtidos no Serviço de Assistência Especializada (SAE) em Divin&oac...
Source: Journal of Coloproctology - Category: Gastroenterology Source Type: research
AbstractThe incidence of therapy-related myelodysplastic syndromes (t-MDS) has been increasing with the widespread use of highly active antiretroviral therapy (HAART) therapy for HIV and chemotherapy for AIDS-related cancers. The classical dysplastic features in the granulocytes and megakaryocytes may not be easily appreciated. The most reliable distinguishing feature between the hematopoietic dysplasia of t-MDS and that of HIV infection rests on the identification of MDS-related cytogenetic aberrations. Here we report a patient with well-controlled HIV and history of chemotherapy for invasive anal squamous cell carcinoma ...
Source: Journal of Hematopathology - Category: Pathology Source Type: research
Authors call for new screening strategies for anal cancer prevention in women living with HIV
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Oncology, Pathology, Surgery, Journal, Source Type: news
We report the incidence and time trends of anal cancer in PLWHIV in Australia. Study design: A data linkage study between the National HIV Registries and the Australian Cancer Database. Methods: Cases of anal squamous cell carcinoma (ASCC) in Australians aged 16 years and above diagnosed with HIV between 1982 and 2012 were identified. Standardized incidence ratios (SIRs) were calculated to compare incidence with that of the general population. Poisson regression models were developed to describe the time trends of ASCC over time and to compare ASCC risk within subgroups of PLWHIV. Results: Among 28 696 individua...
Source: AIDS - Category: Infectious Diseases Tags: EPIDEMIOLOGY AND SOCIAL Source Type: research
(Natural News) It used to be that AIDS was widely regarded as the “gay disease.” But now it’s a transgender disease as well, with new data published by the U.S. Centers for Disease Control and Prevention (CDC) showing that an astounding one in seven transgender “women” are infected with HIV. According to a CDC “Dear...
Source: NaturalNews.com - Category: Consumer Health News Source Type: news
Abstract The advent of highly active antiretroviral therapy (HAART) has significantly reduced the incidence of AIDS events, including AIDS-defining malignancies. Nevertheless, several cohort studies conducted in the post-HAART period have reported an increasing risk of non-AIDS-defining cancers (NADC). Overall, the potential mechanisms leading to an increased risk of developing NADCs probably involve multiple known and unknown factors. In addition to ageing, chronic inflammation and ongoing immune system dysregulation, other contributing factors are the co-infection with potentially oncogenic viruses (HBV, HCV, HP...
Source: Current HIV Research - Category: Infectious Diseases Authors: Tags: Curr HIV Res Source Type: research
ConclusionsThe A-HRSI is able to reliably assess participant-reported symptoms and impacts of anal HSIL across a 7 –10 days of timeframe. Future work will involve the establishment of construct and discriminant validity prior to inclusion in the full ANCHOR trial.
Source: Quality of Life Research - Category: Health Management Source Type: research
This article reviews the current literature on HPV-associated anal cancer in the HIV-infected population, including epidemiology, screening, clinical characteristics, and treatment outcomes. PMID: 30523625 [PubMed - in process]
Source: Anal Sci - Category: Chemistry Authors: Tags: Cancer Treat Res Source Type: research
More News: Anal Cancer | Canada Health | Cancer | Cancer & Oncology | HIV AIDS | Infectious Diseases | Pathology